|
1）Davis SD, Schaller J, Wedgwood RJ. Job's Syndrome. Recurrent, “cold", staphylococcal abscesses. Lancet. 1966; 1: 1013-5
|
|
|
|
|
2）Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics. 1972; 49: 59-70
|
|
|
|
|
3）Grimbacher B, et al. Hyper-IgE syndrome with recurrent infections-an autosomal dominant multisystem disorder. N Engl J Med. 1999; 340: 692-702
|
|
|
|
|
4）Grimbacher B, Holland SM, Puck JM. Hyper-IgE syndromes. Immunol Rev. 2005; 203: 244-50
|
|
|
|
|
|
5）Grimbacher B, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999; 65: 735-44
|
|
|
|
|
|
6）Renner ED, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr. 2004; 144: 93-9
|
|
|
|
|
|
7）Freeman AF, et al. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol. 2007; 119: 1234-40
|
|
|
|
|
|
8）Eberting CL, Davis J, Puck JM, et al. Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol. 2004; 140: 1119-25
|
|
|
|
|
|
9）Hill HR, et al. Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent “cold" staphylococcal abscesses. Lancet. 1974; 2: 617-9
|
|
|
|
|
|
10）Del Prete G, et al. Defective in vitro production of gamma-interferon and tumor necrosis factor-alpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome. J Clin Invest. 1989; 84: 1830-5
|
|
|
|
|
|
11）Borges WG, Augustine NH, Hill HR. Defective interleukin-12/interferon-gamma pathway in patients with hyperimmunoglobulinemia E syndrome. J Pediatr. 2000; 136: 176-80
|
|
|
|
|
|
12）Chehimi J, et al. Cytokine and chemokine dysregulation in hyper-IgE syndrome. Clin Immunol. 2001; 100: 49-56
|
|
|
|
|
|
13）Vercelli D, et al. Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome. J Clin Invest. 1990; 85: 1666-71
|
|
|
|
|
|
14）Rodriguez MF, et al. Interleukin 4 and interferon-gamma secretion by antigen and mitogen-stimulated mononuclear cells in the hyper-IgE syndrome: no TH-2 cytokine pattern. Ann Allergy Asthma Immunol. 1998; 81: 443-7
|
|
|
|
|
|
15）Wood PM, et al. Inherited defects in the interferon-gamma receptor or interleukin-12 signalling pathways are not sufficient to cause allergic disease in children. Eur J Pediatr. 2005; 164: 741-7
|
|
|
|
|
|
16）Minegishi Y, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006; 25: 745-55
|
|
|
|
|
|
17）Velazquez L, Fellous M, Stark GR, et al. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell. 1992; 70: 313-22
|
|
|
|
|
|
18）Shimoda K, et al. Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function. Immunity. 2000; 13: 561-71
|
|
|
|
|
|
19）Karaghiosoff M, et al. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity. 2000; 13: 549-60
|
|
|
|
|
|
20）Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007; 448: 1058-62
|
|
|
|
|